<DOC>
	<DOCNO>NCT00867698</DOCNO>
	<brief_summary>The purpose study determine whether AST-120 safe effective treatment mild hepatic encephalopathy .</brief_summary>
	<brief_title>AST-120 Used Treat Mild Hepatic Encephalopathy</brief_title>
	<detailed_description />
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<criteria>1 . Confirmed cirrhosis cause 2 . Abnormal RBANS global summary score 3 . Grade 0 1 hepatic encephalopathy WestHaven Scale 4 . MELD score &lt; = 25 5 . Females must postmenopausal , surgically incapable bearing child practice reliable method birth control 1 . Previous participation trial involve AST120 2 . History TIPS surgically create portocaval shunt 3 . Treatment overt HE within past 3 month 4 . Use lactulose , rifaximin , neomycin antibiotic past 7 day 5 . Active alcohol abuse 6 . Psychosis organic brain syndrome due alcohol cause 7 . Use interferon sedate cognitionaltering drug 8 . Undergoing chemotherapy radiotherapy treatment cancer 9 . Active GI bleeding within past 3 month 10 . Presence active infection 11 . Presence sign symptom severe dehydration 12 . Other major physical major psychiatric illness within past 6 month 13 . Pregnant , breast feeding , plan become pregnant study 14 . Using hormonal contraception method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Hepatic encephalopathy</keyword>
	<keyword>Mild hepatic encephalopathy</keyword>
	<keyword>HE</keyword>
	<keyword>MHE</keyword>
	<keyword>Cognitive impairment</keyword>
	<keyword>Cognitive dysfunction</keyword>
	<keyword>Liver Disease</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>